Skip to main content

Table 2 Effect of baicalin-lysozyme on metabolic disorder (triglyceride, cholesterol, and malondialdehyde) in rats with diabetic nephropathy

From: Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin

Group

N

TG(umol/g of protein)

TC(umol/g of protein)

MDA(nmol/mg of protein)

Control

10

114.13±36.17

85.1±25.57

2.75±0.67

DN

15

1125.6±154.47***

1544.25±540.13***

12.11±2.42***

DN/B

10

353.42±81.87**###

391.24±48.03###

5.78±0.74**###

DN/B+L

10

203.68±62.34###

308.4±61.69###

3.46±0.49###$

  1. Data are presented as the mean ± standard deviation **P < 0.01 vs. the control group. #P < 0.05, ##P < 0.01 vs. the DN group. $$P < 0.01 vs. the control group